Literature DB >> 15538604

Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study.

K H Kho1, B A Blansjaar, S de Vries, D Babuskova, A H Zwinderman, D H Linszen.   

Abstract

OBJECTIVE: This open label study describes the efficacy of electroconvulsive therapy (ECT) as adjunctive treatment in clozapine nonresponders suffering from schizophrenia.
METHOD: The results of clozapine and ECT treatment in 11 clozapine nonresponders suffering from schizophrenia are reported in terms of remission and relapse.
RESULTS: Eight patients had a remission with this combination treatment. After remission of symptoms five patients had a relapse. Three of the five patients who relapsed had a second successful ECT course and remained well with maintenance ECT and clozapine. No evidence for adverse effects was found.
CONCLUSION: Adjunctive ECT can be efficacious in clozapine nonresponders suffering from schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538604     DOI: 10.1007/s00406-004-0517-y

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

1.  Clozapine does not increase ECT-seizure duration.

Authors:  M Husni; J Haggarty; C Peat
Journal:  Can J Psychiatry       Date:  1999-03       Impact factor: 4.356

2.  ECT following clozapine.

Authors:  S J Masiar; C A Johns
Journal:  Br J Psychiatry       Date:  1991-01       Impact factor: 9.319

Review 3.  When symptoms persist: choosing among alternative somatic treatments for schizophrenia.

Authors:  G W Christison; D G Kirch; R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

4.  Duration of a clozapine trial in neuroleptic-resistant schizophrenia.

Authors:  H Y Meltzer
Journal:  Arch Gen Psychiatry       Date:  1989-07

5.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

6.  Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

Authors:  M H Kronig; R A Munne; S Szymanski; A Z Safferman; S Pollack; T Cooper; J M Kane; J A Lieberman
Journal:  Am J Psychiatry       Date:  1995-02       Impact factor: 18.112

7.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

8.  Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials.

Authors:  K Wahlbeck; M Cheine; A Essali; C Adams
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

9.  Clozapine in the treatment of psychotic refractory depression.

Authors:  D Dassa; A Kaladjian; J M Azorin; S Giudicelli
Journal:  Br J Psychiatry       Date:  1993-12       Impact factor: 9.319

10.  Seizure activity in combined clozapine and ECT: a retrospective view.

Authors:  B A Cardwell; B Nakai
Journal:  Convuls Ther       Date:  1995-06
View more
  16 in total

1.  Antipsychotic Polypharmacy.

Authors:  Adriana Foster; Jordanne King
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 2.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Impacts of Electroconvulsive Therapy on 1-Year Outcomes in Patients With Schizophrenia: A Controlled, Population-Based Mirror-Image Study.

Authors:  Hai-Ti Lin; Shi-Kai Liu; Ming H Hsieh; Yi-Ling Chien; I-Ming Chen; Shih-Cheng Liao; Hui-Ju Tsai; Chi-Shin Wu
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

4.  Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas.

Authors:  Diana Kristensen; Jeanett Bauer; Ida Hageman; Martin Balslev Jørgensen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-05       Impact factor: 5.270

5.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

6.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

7.  Delayed onset, protracted delirium and aspiration pneumonitis associated with a combination of clozapine and electroconvulsive therapy.

Authors:  N Manjunatha; G S Ram Kumar; R Vidyendaran; K Muralidharan; J P John
Journal:  Indian J Psychol Med       Date:  2011-01

8.  Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review.

Authors:  José M Olivares; Jan Sermon; Michiel Hemels; Andreas Schreiner
Journal:  Ann Gen Psychiatry       Date:  2013-10-23       Impact factor: 3.455

9.  Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.

Authors:  Wei Zheng; Xiao-Lan Cao; Gabor S Ungvari; Ying-Qiang Xiang; Tong Guo; Zheng-Rong Liu; Yuan-Yuan Wang; Brent P Forester; Stephen J Seiner; Yu-Tao Xiang
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

10.  Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study.

Authors:  Victor M Tang; Daniel M Blumberger; Shawn M McClintock; Tyler S Kaster; Tarek K Rajji; Jonathan Downar; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Front Psychiatry       Date:  2018-01-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.